Abstract CT212: A phase III randomized study of paclitaxel (T) and trastuzumab (H) versus T, H and lapatinib (L) in first line treatment of HER2+ metastatic breast cancer (MBC)
John Crown
◽
William Jacot
◽
Denis M. Collins
◽
Linda Coate
◽
Anna Saetersdal
◽
...
JP Crown
◽
B Moulton
◽
N O'Donovan
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS102-TPS102
◽
P. A. Ellis
◽
C. H. Barrios
◽
Y. Im
◽
M. Patre
◽
F. Branle
◽
...
2010 ◽
Vol 28
(S1)
◽
pp. 142-151
◽
M. Ghosn
◽
P. Aftimos
◽
F. S. Farhat
◽
J. G. Kattan
◽
C. Hanna
◽
...
1999 ◽
Vol 35
◽
pp. S315
◽
S. Chan
◽
N. Davidson
◽
E. Juozaityte
◽
F. Erdkamp
◽
L. Hooftman
◽
...
2010 ◽
Vol 79
(3-4)
◽
pp. 197-203
◽
Hans-Joachim Stemmler
◽
Nadia Harbeck
◽
Isolde Gröll de Rivera
◽
Ursula Vehling Kaiser
◽
Gerhard Rauthe
◽
...
2005 ◽
Vol 16
(8)
◽
pp. 871-877
◽
G. von Minckwitz
◽
I. Chernozemsky
◽
L. Sirakova
◽
P. Chilingirov
◽
R. Souchon
◽
...
K Najagami
◽
K Inoue
◽
M Mizutani
◽
Y Hozumi
◽
Y Fujiwara
◽
...
2014 ◽
Vol 149
(1)
◽
pp. 171-179
◽
Michael R. Clemens
◽
Oleg A. Gladkov
◽
Elaina Gartner
◽
Vladimir Vladimirov
◽
John Crown
◽
...
2007 ◽
Vol 41
(6)
◽
pp. 555-562
◽
P Biron
◽
M Durand
◽
H Roché
◽
T Delozier
◽
C Battista
◽
...
Close
Export Citation Format
Close
Share Document
Close